Skip to content

Perbak Capital Partners LLP: TMUS position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Perbak Capital Partners LLP on TMUS, newest first. How the timeline and the estimate are built.

Perbak Capital Partners LLP held 0 TMUS shares at 2025-09-30 per its 13F-HR filed 2025-11-13.

the latest 13F is the newest step

  1. period ended2025-09-30
    13F 0 shares
    Change vs previous 13F -7,331 shares

    13F-HR 0000902664-25-004905 filed by Perbak Capital Partners LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-06-30
    13F 7,331 shares
    Change vs previous 13F +4,216 shares

    0.39% of the 13F portfolio, value $1,746,684.

    13F-HR 0000902664-25-003680 filed by Perbak Capital Partners LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-03-31
    13F 3,115 shares
    Change vs previous 13F -6,735 shares

    0.62% of the 13F portfolio, value $830,802.

    13F-HR 0000902664-25-002434 filed by Perbak Capital Partners LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2024-12-31
    13F 9,850 shares
    Change vs previous 13F -8,845 shares

    1.16% of the 13F portfolio, value $2,174,191.

    13F-HR 0000902664-25-001074 filed by Perbak Capital Partners LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-09-30
    13F 18,695 shares
    Change vs previous 13F not available

    2.71% of the 13F portfolio, value $3,857,900.

    13F-HR 0000902664-24-006609 filed by Perbak Capital Partners LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).